Brind.

Redwire formed SpaceMD to commercialize pharma development, using microgravity results to inform an IND application to the FDA.

1 report, 1 independent Updated Aug 5

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Redwire FDA

How it developed

Newest first. Tap a step to see who reported it.

Aug 14Space Cargo Unlimited and Transcell Biologics are investigating microgravity for drug development.Sub-event
Aug 5Redwire/SpaceMD is leveraging space environment for pharmaceutical development and FDA submission.1 source
- Business Wire

Keep exploring

The entities involved

Redwire
American public aerospace developer and manufacturer
- Jefferies Financial Group published research reports regarding Redwire stock on May 26, 2026.Sun 00:56
FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Coverage

Newest first; wire copies grouped

Aug 5Business WireRedwire Launches New Venture Company, SpaceMD, to Commercialize Pharmaceutical Development in Space; Signs Trailblazing Royalty Agreement with ExesaLibero Pharma JACKSONVILLE, Fla., August 04, 2025--